Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Add To Watchlist

TSX:LABS - Post Discussion

Medipharm Labs Corp > Increased exposure through product in Germany wont hurt

View:

Post by mdjbrown on Mar 26, 2024 11:00am

Increased exposure through product in Germany wont hurt

Medipharm in the long run. Almost tripling product approvals is a good start to 2024

"Thus far in 2024, MediPharm has increased the German product approvals under the Beacon Medical brand from 5 to 14"

Lets see if Medipharm numbers increase substantially from last years financial reporting at this time

Most of MediPharm’s sales in the January-March quarter were in Canada.

"By jurisdiction, the company’s revenue was:

CA$3.9 million in Canada.
CA$51,000 in Australia.
CA$1.2 million in Germany.
CA$575,000 in other, unspecified places.

MediPharm’s sales in the Canadian adult-use and wellness sector were C$3.5 million in the first quarter, up from CA$2.5 million in the same period last year.

International medical cannabis sales amounted to CA$1.8 million, up from CA$1.3 million in the first quarter last year."